Stoke Therapeutics (STOK) Enterprise Value Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86% |
| Dec 31, 2025 | -31.25% |
| Sep 30, 2025 | 44.44% |
| Jun 30, 2025 | 47.53% |
| Mar 31, 2025 | -100.09% |
| Dec 31, 2024 | -7.70% |
| Sep 30, 2024 | 30.10% |
| Jun 30, 2024 | 16.37% |
| Mar 31, 2024 | 29.60% |
| Dec 31, 2023 | 12.28% |
| Sep 30, 2023 | 14.68% |
| Jun 30, 2023 | 16.03% |
| Mar 31, 2023 | 13.49% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | -68.69% |
| Jun 30, 2022 | -9.71% |
| Mar 31, 2022 | -9.55% |
| Dec 31, 2021 | 23.49% |
| Sep 30, 2021 | 22.08% |
| Jun 30, 2021 | -24.41% |
| Mar 31, 2021 | -26.68% |
| Dec 31, 2020 | -29.14% |
| Sep 30, 2020 | 17.85% |
| Jun 30, 2020 | 16.79% |
| Mar 31, 2020 | -114.18% |
| Dec 31, 2019 | -111.08% |
| Sep 30, 2019 | -1,103.33% |
| Jun 30, 2019 | -2,442.22% |